NO985412L - Type-2 kjemokinbindende proteiner og anvendelser derav - Google Patents

Type-2 kjemokinbindende proteiner og anvendelser derav

Info

Publication number
NO985412L
NO985412L NO985412A NO985412A NO985412L NO 985412 L NO985412 L NO 985412L NO 985412 A NO985412 A NO 985412A NO 985412 A NO985412 A NO 985412A NO 985412 L NO985412 L NO 985412L
Authority
NO
Norway
Prior art keywords
type
chemokine binding
binding proteins
poxviruses
cbp
Prior art date
Application number
NO985412A
Other languages
English (en)
Norwegian (no)
Other versions
NO985412D0 (no
Inventor
Grant Mcfadden
Alexandra Lucas
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Publication of NO985412D0 publication Critical patent/NO985412D0/no
Publication of NO985412L publication Critical patent/NO985412L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO985412A 1996-05-22 1998-11-20 Type-2 kjemokinbindende proteiner og anvendelser derav NO985412L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1813796P 1996-05-22 1996-05-22
PCT/US1997/008590 WO1997044054A2 (en) 1996-05-22 1997-05-21 Type-2 chemokine binding proteins and methods of use therefor

Publications (2)

Publication Number Publication Date
NO985412D0 NO985412D0 (no) 1998-11-20
NO985412L true NO985412L (no) 1999-01-20

Family

ID=21786445

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985412A NO985412L (no) 1996-05-22 1998-11-20 Type-2 kjemokinbindende proteiner og anvendelser derav

Country Status (21)

Country Link
EP (1) EP0901379B1 (da)
JP (1) JP2000511535A (da)
KR (1) KR20000015895A (da)
CN (1) CN1226171A (da)
AT (1) ATE196091T1 (da)
AU (1) AU3136197A (da)
BR (1) BR9710028A (da)
CA (1) CA2256568A1 (da)
CZ (1) CZ378998A3 (da)
DE (1) DE69703040T2 (da)
DK (1) DK0901379T3 (da)
ES (1) ES2152095T3 (da)
GR (1) GR3034805T3 (da)
HK (1) HK1017622A1 (da)
IL (1) IL127166A0 (da)
NO (1) NO985412L (da)
NZ (1) NZ333456A (da)
PL (1) PL330149A1 (da)
PT (1) PT901379E (da)
TR (1) TR199802392T2 (da)
WO (1) WO1997044054A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
GB9916703D0 (en) * 1999-07-16 1999-09-15 Alcami Antonio Viral protein binding compositions and methods
WO2001087324A1 (en) * 2000-05-17 2001-11-22 Viron Therapeutics, Inc. Compositions and methods for promoting immunosuppression
CA2412279A1 (en) 2000-09-08 2002-03-14 Gryphon Therapeutics, Inc. "pseudo"-native chemical ligation
EP2357002A1 (en) 2000-10-11 2011-08-17 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
CA2428097A1 (en) * 2000-12-04 2002-06-13 Viron Therapeutics, Inc. Immunomodulatory protein derived from the yaba monkey tumor virus
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
DE10162869A1 (de) * 2001-12-20 2003-07-31 Alexander Cherkasky Invasive lineare halb-zyklische und zyklische Systeme zur Herauslockung der Krankheitserreger
GB0304531D0 (en) * 2003-02-27 2003-04-02 Isis Innovation Treatment
MXPA05011886A (es) * 2003-05-15 2006-02-17 Tanox Inc Metodos y composiciones para la prevencion y tratamiento de septicemia.
AU2004269903B2 (en) 2003-09-09 2010-09-02 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
EP2137537B8 (en) 2007-02-08 2016-06-01 Biogen MA Inc. Compositions and Uses for Treating Multiple Sclerosis
CN113234137B (zh) * 2021-06-21 2022-02-25 华中农业大学 分离自草鱼的CXCL20a蛋白在作为抗菌肽中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0604418T3 (da) * 1991-03-29 1999-06-14 Immunex Corp Isolerede viralproteincytokinantagonister
US5834419A (en) * 1995-04-19 1998-11-10 The John P. Robarts Institute Chemokine binding protein and methods of use therefor
IL123653A0 (en) * 1995-09-29 1998-10-30 Immunex Corp Chemokine inhibitor

Also Published As

Publication number Publication date
CN1226171A (zh) 1999-08-18
DK0901379T3 (da) 2000-12-27
BR9710028A (pt) 1999-08-10
HK1017622A1 (en) 1999-11-26
JP2000511535A (ja) 2000-09-05
EP0901379B1 (en) 2000-09-06
CZ378998A3 (cs) 1999-07-14
EP0901379A2 (en) 1999-03-17
AU3136197A (en) 1997-12-09
CA2256568A1 (en) 1997-11-27
WO1997044054A3 (en) 1998-05-14
TR199802392T2 (xx) 1999-02-22
ES2152095T3 (es) 2001-01-16
KR20000015895A (ko) 2000-03-15
IL127166A0 (en) 1999-09-22
DE69703040D1 (de) 2000-10-12
ATE196091T1 (de) 2000-09-15
PT901379E (pt) 2001-02-28
NZ333456A (en) 2000-08-25
DE69703040T2 (de) 2001-05-03
WO1997044054A2 (en) 1997-11-27
GR3034805T3 (en) 2001-02-28
PL330149A1 (en) 1999-04-26
NO985412D0 (no) 1998-11-20

Similar Documents

Publication Publication Date Title
DK0840615T3 (da) Kemokin-bindende protein og fremgangsmåder til anvendelse deraf
NO985412D0 (no) Type-2 kjemokinbindende proteiner og anvendelser derav
IL161016A (en) Polypeptides capable of ang-2 binding
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
DE69433406D1 (de) Antikörper gegen cd40
WO2002032925A3 (en) Protein scaffolds for antibody mimics and other binding proteins
BR0009206A (pt) Isolamento e análise de proteina
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DK1017715T3 (da) Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
ATE301194T1 (de) Beta-defensine
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
BR0315222A (pt) Promotor de il-18bp, sua preparação e uso
DK223290A (da) Hidtil ukendt protein til konstatering af draegtighed hos pattedyr, anvendelse af proteinet til tidlig paavisning af draegtighed og fremgangsmaade til fremstilling af proteinet
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling
BRPI0216042B8 (pt) polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application